Cystic fibrosis future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]

In cystic fibrosis therapies under investigation include prophylactic ursodiol therapy; CF corrector VX-661; inhaled dry powder mannitol and CFTR gene therapy.

In cystic fibrosis therapies under investigation include:^[1]

• Prophylactic ursodiol therapy
• CF corrector VX-661
• Inhaled dry powder mannitol
• CFTR gene therapy